BSEAGM/EGM2d ago · 27 Jul 2026, 09:10 pm
The 8th Annual General Meeting of the Members of Entero Healthcare Solutions Limited is scheduled to be held on Wednesday, August 19, 2026, at 12:30 p.m. (IST) through Video Conferencing/Other ....
Entero Healthcare Solutions Ltd · 544122
✦ AI Summary
Entero Healthcare Solutions Ltd has scheduled its 8th Annual General Meeting (AGM) on August 19, 2026, through video conferencing. The company has dispatched its annual report for the financial year 2025-26, along with the AGM notice, to its members via email and made it available on its website.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Entero Healthcare Solutions Ltd - 544122 - Notice Convening The 8Th Annual General Meeting
Attachments (1)
📄pdf
Download →
2a6649a2-aae1-4aa7-8ffa-38f036a3808f.pdf
View document text
Ref: 21/SE/LC/2026-27 Date: July 27, 2026
Scrip Code BSE: 544122
NSE: ENTERO
ISIN: INE010601016
Head, Listing Compliance Department Head, Listing Compliance Department
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Dalal Street, Exchange Plaza, Plot No. C/1. G Block,
Mumbai - 400001 Bandra -Kurla Complex, Bandra (East),
Mumbai- 400051
Dear Sir/Madam,
Subject: Annual Report for the financial year 2025-26 along with the Notice convening the 8th
Annual General Meeting (“AGM”)
This is further to our intimation letter dated May 25, 2026, bearing reference number
06/SE/LC/2026-27, we hereby inform you that 8th AGM of the Members of Entero Healthcare
Solutions Limited (“the Company”) will be held on Wednesday, August 19, 2026, at 12:30 p.m.
(IST) through Video Conferencing (VC)/Other Audio - Visual Means (OAVM), in compliance with
the applicable circulars issued by Ministry of Corporate Affairs and Securities and Exchange
Board of India.
Pursuant to Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, please find enclosed the Annual Report of the Company for the financial year
2025-26 along with the AGM Notice. The Annual Report and AGM Notice are dispatched through
electronic mode to all Members whose e-mail addresses are registered with the
Company/Registrar and Share Transfer Agent/Depository Participant(s).
Further, pursuant to Regulation 36 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, the Company has dispatched a letter to the Members whose e-mail
addresses are not registered with the Company/ Registrar & Share Transfer Agent/Depository
Participant(s), providing a web-link for accessing the Annual Report and AGM Notice as available
on the Company's website at Entero
Details of the 8th Annual General Meeting:
Particulars Details
Date and Time of 8th AGM Wednesday, August 19, 2026, at 12:30 p.m.
Venue / Mode Video Conferencing / Other Audio & Visual Means
Cut-off date Wednesday, August 12, 2026
Commencement of E-Voting Sunday, August 16, 2026, at 9:00 a.m. (IST)
End of E-Voting Tuesday, August 18, 2026, at 5:00 p.m. (IST)
The above information is also made available on the website of the Company at
www.enterohealthcare.com
This is for your information and records.
Yours faithfully,
For Entero Healthcare Solutions Limited
Sanu Kapoor
Vice president- Group General Counsel,
Company Secretary & Compliance Officer
Encl: as above
NNEEXXTT IISS NNOOWW
EEXXPPAANNDDIINNGG HHOORRIIZZOONNSS I NIN
HHEEAALLTTHHCCAARREE
AANNNNUUAALL RREEPPOORRTT 22002255--2266
TABLE OF CORPORATE OVERVIEW
CONTENTS 01 Theme Introduction
02 Entero At a Glance
PG. 01-28 18 Board of Directors
19 Chairman's Message
20 MD & CEO's Message
22 Entero's Philosophy
23 Entero’s Value Proposition
24 CSR Activity
26 Performance Highlights
27 Operational Highlights
28 Corporate Information
STATUTORY REPORTS
29 Management Discussion and A nalysis
Entero House
35 Board’s Report
PG. 29-98 58 Corporate Governance R eport
76 Business Responsibility and Sustainability Report
03 FINANCIAL STATEMENTS
99 Standalone Financial S tatements
171 Consolidated Financial S tatements
PG. 99-247
NOTICE OF AGM
PG. 250-270
To download or to read
this report online, please log on to
https://www.enterohealthcare.com/
NEXT IS NOW Building the
Healthcare Platform
EXPANDING HORIZONS IN
of Tomorrow, with
HEALTHCARE
Scale, Speed &
Intelligence, Today.
The future of healthcare is being shaped by speed, At its core, Entero embodies a belief that meaningful progress
connectivity and the ability to respond to evolving patient is driven by the courage to anticipate change and the
needs with greater precision and purpose. Across the commitment to lead it. As healthcare continues to evolve, the
healthcare ecosystem, boundaries are being rede ned as journey ahead will belong to those who are ready to shape the
technology, access and innovation come together to create future with vision, purpose and responsibility.
more integrated and efficient models of care. In this changing
landscape, progress belongs to organizations that are
prepared to think ahead, adapt faster and build with a long-
term vision.
“Next is Now” re ects a mindset of continuous evolution —
one that embraces transformation not as a future aspiration,
but as a present-day responsibility. It represents the pursuit of
broader possibilities across healthcare delivery, supply chains,
patient engagement and digital enablement. As the industry
moves toward smarter, more connected ecosystems, the focus
is shifting from scale alone to sustainable impact, agility and
resilience.
Expanding horizons in healthcare also means strengthening
collaboration across stakeholders, unlocking new
opportunities for innovation and enabling seamless access to
healthcare solutions. It is about creating ecosystems that are
more responsive, transparent and future-ready, while
remaining anchored in trust and reliability.
ANNUAL REPORT 2025-26
ENTERO
AT A GLANCE
STRENGTHENING
THE CORE,
EXPANDING
THE REACH
Entero Healthcare Solutions is building one of India’s most FY26 marked a signi cant milestone in Entero’s evolution. The
comprehensive and integrated healthcare distribution Company delivered ₹6,591 crore in revenue, representing
platforms, connecting healthcare manufacturers, pharmacies, 29.3% reported growth and 31.5% like-for-like growth,
hospitals, and healthcare providers through a technology- substantially outperforming the Indian Pharmaceutical
enabled nationwide network. Market (IPM). Organic growth remained strong at 15.6%,
enabling Entero to consistently gain market share while
Operating in a healthcare supply chain industry valued at over maintaining disciplined execution.
USD 33 billion, Entero addresses one of the largest and most
fragmented opportunities within India’s healthcare The Company’s platform today serves 105,300+ Retail
ecosystem. By combining scale, technology, operational Pharmacy Customers, 3,600+ Hospital Customers, 523
excellence, and strategic acquisitions, the Company is creating Districts Covered, 136 Warehouses, 97,500+ SKUs Handled and
a platform designed to improve accessibility, efficiency, and 3,300+ Manufacturer Relationships. This extensive network
reliability across the healthcare value chain. enables timely product availability, efficient inventory
02 NEXT IS NOW EXPANDING HORIZONS IN HEALTHCARE
CORPORATE STATUTORY FINANCIAL NOTICE FOR
OVERVIEW REPORTS STATEMENTS AGM
management, and deep market penetration across urban, rapidly growing MedTech segment. Through a combination of
semi-urban, and emerging healthcare markets. organic initiatives and strategic acquisitions, the Company
established meaningful scale across diagnostics, medical
A de ning development during FY26 was Entero’s expansion devices, cardiology, orthopaedics, consumables, and imaging-
beyond traditional pharmaceutical distribution into the related products.
Entero is transforming scale into
sustainable growth, pro tability, & healthcare access across India.
6.29 Lakh + Sq. Ft in
50 CITIES
End to End cold chain
INFRASTRUCTURE
COMPLIANT
The MedTech business is expected to contribute more than Operational discipline and working capital optimization
₹1,000 crore of annualized revenue in FY27, signi cantly enabled Entero to achieve ₹96 crore in operating cash ow, a
expanding Entero’s addressable market while strengthening signi cant milestone in the Company’s growth journey. Net
its margin pro le and long-term growth prospects. working capital improved to 59 days by Q4 FY26, while return
metrics strengthened meaningfully, with ROCE increasing to
Technology remains central to Entero’s operating model. 14.6% and ROE improving to 12.5%.
Proprietary digital platforms enable real-time inventory
visibility, intelligent procurement, demand forecasting, As healthcare distribution continues to consolidate and
warehouse optimization, and data-driven decision making. formalize, Entero is uni
[Showing first 8,000 characters — download PDF for full document]